Author(s): Preeti Chaudhary, Rupesh Pingale, Suyash Ambekar, Vedika Dagadkhair, Diksha Patil,

Email(s): chpreeti03@gmail.com

DOI: 10.52711/0974-360X.2026.00446   

Address: Preeti Chaudhary, Rupesh Pingale, Suyash Ambekar, Vedika Dagadkhair, Diksha Patil
Department of Pharmacy, NCRD's Sterling Institute of Pharmacy, Nerul, Navi Mumbai, Maharashtra, India.
*Corresponding Author

Published In:   Volume - 19,      Issue - 7,     Year - 2026


ABSTRACT:
Kidney stones are a common and recurring urological condition worldwide, requiring effective treatment strategies. The incidence of pediatric urolithiasis has increased globally over the past few decades. This study focuses on the formulation and in vitro evaluation of polyherbal syrups for their potential antiurolithiatic activity. The selected polyherbal formulations were designed for ease of administration, particularly for pediatric and geriatric populations, who may struggle with tablets or capsules. The formulations were compared with the widely marketed antiurolithiatic preparation, Cystone, as a standard reference. Phytochemical screening of the selected plants revealed the presence of bioactive compounds such as phenolic compounds, tannins, and flavonoids, which are known to exhibit antiurolithiatic properties. The antiurolithiatic activity was assessed through in vitro crystallization inhibition assays, and the results were compared with those obtained from Cystone. Additionally, the identification of key bioactive components was performed using UV spectrophotometry. The findings demonstrated that the polyherbal syrup formulations exhibited significant antiurolithiatic activity comparable to or better than the marketed preparation, Cystone. This suggests that polyherbal syrups could serve as an effective and patient-friendly alternative for the prevention and management of kidney stones. Further research on clinical efficacy is warranted to explore the full potential of these formulations.


Cite this article:
Preeti Chaudhary, Rupesh Pingale, Suyash Ambekar, Vedika Dagadkhair, Diksha Patil. In-vitro Evaluation of Polyherbal Syrups for Anti-Urolithiatic Activity: A Comparison with Cystone. Research Journal of Pharmacy and Technology. 2026;19(7):3143-0. doi: 10.52711/0974-360X.2026.00446

Cite(Electronic):
Preeti Chaudhary, Rupesh Pingale, Suyash Ambekar, Vedika Dagadkhair, Diksha Patil. In-vitro Evaluation of Polyherbal Syrups for Anti-Urolithiatic Activity: A Comparison with Cystone. Research Journal of Pharmacy and Technology. 2026;19(7):3143-0. doi: 10.52711/0974-360X.2026.00446   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-7-33


REFERENCES: 
1.    Shastri S, Patel J, Sambandam KK, Lederer ED. Kidney stone pathophysiology, evaluation and management: core curriculum 2023. Am J Kidney Dis. 2023; 82(5): 617 634.
2.    Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, et al. Kidney stones. Nat Rev Dis Primers. 2016 Feb 25; 2: 16008. doi:10.1038/nrdp.2016.8. PMID:27188687; PMCID:PMC5685519.
3.    Wang Z, Zhang Y, Zhang J, Deng Q, Liang H. Recent advances on the mechanisms of kidney stone formation. Int J Mol Med. 2021 Aug; 48(2): 149. doi:10.3892/ijmm.2021.4982. PMID: 34132361; PMCID:PMC8208620.
4.    Allam EAH. Urolithiasis unveiled: pathophysiology, stone dynamics, types, and inhibitory mechanisms. Afr J Urol. 2024; 30(34): 1 12. doi:10.1186/s12301 024 00436 z.
5.    Kushagra D, Rajiv S, Ruchi G, Neelesh M. In-Vitro Evaluation of Anti-Urolithic Activity of Leaves Extract of Costus igneus. Research J. Pharm. and Tech. 2020; 13(3): 1289-1292.
6.    Zhang L, Zhang X, Pu Y, Zhang Y, Fan J. Global, regional, and national burden of urolithiasis from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study. 2019. Clin Epidemiol. 2022; 14: 971 983. doi:10.2147/CLEP.S370591. PMID:35996396; PMCID:PMC9391934.
7.    Kumar B, Kothiyal P, Mukhopadhyay S. Advancements in urolithiasis treatment: current strategies, future challenges, and integrating traditional wisdom into modern medicine. Int J Pharm Qual Assur. 2024; 15(2): 1094 1103.
8.    Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014; 4: 177. doi:10.3389/fphar.2013.00177. PMID:24454289; PMCID:PMC3887317.
9.    Khokhlenkova NV, Buryak MV, Povrozina OV, Kamina TV. Principles of the Urolithiasis Phytotherapy. Research J. Pharm. and Tech. 2019; 12(9): 4559-4564.
10.    Mehrabi S, Behnam P, Manzouri L, Mehrabi A. Comparison of efficacy and side effects of combined cystone and hydrochlorothiazide with cystone monotherapy in treatment and passage of upper urinary stones: a randomized clinical trial. J Renal Inj Prev. 2019; 8(3): 211 215.
11.    Hewagama SP, Hewawasam RP. Antiurolithiatic potential of three Sri Lankan medicinal plants by the inhibition of nucleation, growth, and aggregation of calcium oxalate crystals in vitro. Scientific World Journal. 2022; 2022: 8657249. doi:10.1155/2022/8657249. PMID:35463824; PMCID:PMC9019441.
12.    Vishal, Dahiya DP, Sankhyan A, Sharma A. An updated review on Phyllanthus niruri: its phytochemistry, pharmacological activity, medicinal use and traditional use. Int J Pharm Sci. 2025; 3(3): 2022 2027. doi:10.5281/zenodo.15062486.
13.    Chhatre S, Nesari T, Somani G, Kanchan D, Sathaye S. Phytopharmacological overview of Tribulus terrestris. Pharmacogn Rev. 2014;8(15):45 51.
14.    Agarwal S, Gupta SJ, Saxena AK, Gupta N, Agarwal S. Urolithic property of varuna (Crataeva nurvala): an experimental study. Ayu. 2010; 31(3): 361 366. doi:10.4103/0974 8520.77161. PMID:22131740; PMCID:PMC3221072.
15.    Mittal A, Tandon S, Singla SK, Tandon C. In vitro studies reveal antiurolithic effect of Terminalia arjuna using quantitative morphological information from computerized microscopy. Int Braz J Urol. 2015; 41(5): 935 944. doi:10.1590/S1677 5538.IBJU.2014.0547. PMID:26689519; PMCID:PMC4756970.
16.    Abubakar AR, Haque M. Preparation of medicinal plants: basic extraction and fractionation procedures for experimental purposes. J Pharm Bioallied Sci. 2020; 12(1): 1 10. doi:10.4103/jpbs.JPBS_175_19. PMID:32801594; PMCID:PMC7398001.
17.    Chaudhary P, Dhingra G, Pingale R. GC-MS Evaluation of Bioactive Constituents of Hydroalcoholic Leaves Extract of Pongamia pinnata with Antibacterial Potential of Prepared Mouthwash Formulations. Research Journal of Pharmacy and Technology. 2024; 17(10): 4811-6.
18.    Ahmad W, Jawed R, Thakur Y, Thakur R. In-vitro Assessment of Antiurolithiatic activity of Tridax procumbens Flower Extracts. Research Journal of Pharmaceutical Dosage Forms and Technology. 2023; 15(3): 157-2.
19.    Bandal TG, Khopade AA, Awate PB, Shete RV, Fajage DV. Formulation and evaluation of herbal syrup. Int J Creat Res Thoughts. 2024; 12(5): b409 b412.
20.    Sharma S, Baghel DS, Mittal A, Singh S, Kumar B, Prabhakar PK, Chaudhary AK. Polyherbal Formulation Development and Assessment of its Potential against Urolithiasis (Mutrakricchra) by In-Vitro Technique. Research Journal of Pharmacy and Technology. 2021; 14(4): 1982-8.
21.    Sheikh JA, Zahoor A, Khan SS, Khan U. Design, development and phytochemical evaluation of a polyherbal formulation (Linkus syrup). Chin Med. 2014; 5: 104 112.
22.    Raj S, Rajan MSG S, Ramasamy S, Goldy RIRS, Ariyamuthu R, Sudhagar M. In vitro anti urolithiasis activity of a herbal formulation: Spinacia oleracea L. and Coriandrum sativum L. Clin Complement Med Pharmacol. 2024; 4: 100124.
23.    Chandrasekar R, R. Pavithra, B. Vandana, R. Babitha, S. Tejoprasanna, B. Sandeep, G. Deepika, M. Niranjan Babu. Evaluation of in vitro Antiurolithiatic Potential of Ethanolic Leaf Extract of Langerstromia specoisa. Research Journal of Pharmacognosy and Phytochemistry. 2022; 14(3): 150-4.
24.    Neeraja Kamakshi. U, Ganga Rao. B, Venkateswara Rao. B. Comparison of In vitro Antiurolithiatic Activity of Aerva lanata, Sphaeranthus indicus, Merremia emarginata. Research J. Pharm. and Tech. 2017; 10(6): 1653-1656.
25.    Paheerathan VS, Senevirathne AAI. In vitro evaluation of anti urolithiatic activity of Cuminum cyminum seed extract on calcium oxalate stone. Nat Ayurvedic Med. 2023; 7(1): 000370.
26.    Spandana. K, Shivani. M, Himabindhu. J, Ramanjaneyulu. K. Evaluation of In Vitro Antiurolithiatic Activity of Vigna radiata. Research J. Pharm. and Tech. 2018; 11(12): 5455-5457.
27.    Yenduri Suvarna, S K. Abdul Rahaman. In Vitro – In Vivo Evaluation of Antiurolithiatic activity of piperine from Piper nigrum. Research J. Pharm. and Tech. 2020; 13(1): 63-68.
28.    Hennequin C, Lalanne V, Daudon M, Lacour B, Drueke T. A new approach to studying inhibitors of calcium oxalate crystal growth. Urol Res. 1993; 21: 101 108. doi:10.1007/BF01788827.
29.    Omar M, Ali I, Mohamed YM, Hicham B, Lotfi M, Abdelkrim R, Mohamed LB, Noureddine E, Djamel G, Bachir BS. In vitro Antiurolithiatic activity of the leaves and flowers extracts of Paronychia argentea, a plant used in traditional medicine in Algeria. Asian Journal of Research in Chemistry. 2021; 14(6): 401-1.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.52711/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available